What is 6955.HK's current stock price?

6955.HK (Shandong Boan Biotechnology Co., Ltd.) is currently trading at HK$3.76 with a market cap of HK$2.34B.

What sector is Shandong Boan Biotechnology Co., Ltd. in?

Shandong Boan Biotechnology Co., Ltd. (6955.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

6955.HK Shandong Boan Biotechnology Co., Ltd.

HKSEHealthcare

HK$3.76-2.46%LatestMarket Cap: HK$2.34B

As of 2026-08-27 16:08

Why 6955.HK matters now

Shandong Boan Biotechnology Co., Ltd. (6955.HK) is a Hong Kong stock in Healthcare. The latest InvestLog snapshot shows HK$3.76 with -2.46% on the session and HK$2.34B in market capitalization.

InvestLog's latest related AI research is a Earnings Release note titled "Shandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 financial results".

Related AI Research

Earnings ReleaseAug 27, 2026

Shandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 financial resultsShandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 财报发布

Shandong Boan Biotechnology Co., Ltd. reported revenue CN¥233M, net income -CN¥83M.Shandong Boan Biotechnology Co., Ltd. 公布2026 H1财报：营收 CN¥233M，净利润 -CN¥83M。

Listing Info

Market

Hong Kong

Exchange

HKSE

Currency

HKD

Sector

Healthcare

Industry

Biotechnology

Country

Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.